Biological
Typhoid Vi vaccine
Typhoid Vi vaccine is a biological therapy with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
4(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 44 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_4
Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
NCT00125008
completedphase_4
Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
NCT00125047
completedphase_4
Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam
NCT00131820
completedphase_4
Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
NCT00131833
Clinical Trials (4)
Showing 4 of 4 trials
NCT00125008Phase 4
Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
NCT00125047Phase 4
Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
NCT00131820Phase 4
Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam
NCT00131833Phase 4
Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4